fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2023

British journal of cancer

Nannan L

A multimodal imaging study to highlight elastin-derived peptide pro-tumoral effect in a pancreatic xenograft model.

2023

Journal of medicinal chemistry

Godard A

NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer.

2023

Bioconjugate chemistry

Privat M

First Comparison Study of the and Properties of a Randomly and Site-Specifically Conjugated SPECT/NIRF Monomolecular Multimodal Imaging Probe (MOMIP) Based on an aza-BODIPY Fluorophore.

2023

BMC medical research methodology

Botta L

A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data.

2023

International review of cell and molecular biology

Baude J

Combining radiotherapy and NK cell-based therapies: The time has come.

2023

European journal of cancer (Oxford, England : 1990)

Bascoul-Mollevi C

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.

2023

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Brugel M

Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pancreatic adenocarcinoma: A retrospective single-centre observational study.

2023

Cancers

Meunier S

Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation.

2023

International journal of molecular sciences

Dubois-Pot-Schneider H

Transcriptomic Study on Human Skin Samples: Identification of Two Subclasses of Actinic Keratoses.

2023

European journal of applied physiology

Hucteau E

Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.